Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Shock ; 24(2): 132-8, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16044083

ABSTRACT

Lung contusion is the leading cause of death from blunt thoracic trauma in adults, but its mechanistic pathophysiology remains unclear. This study uses a recently developed rat model to investigate the evolution of inflammation and injury in isolated lung contusion. Bilateral lung contusion with minimal cardiac trauma was induced in 54 anesthetized rats by dropping a 0.3-kg hollow cylindrical weight onto a precordial shield (impact energy, 2.45 Joules). Arterial oxygenation, pressure-volume (P-V) mechanics, histology, and levels of erythrocytes, leukocytes, albumin, and inflammatory mediators in bronchoalveolar lavage (BAL) were assessed at 8 min, at 4, 12, 24, and 48 h, and at 7 days after injury. The role of neutrophils in the evolution of inflammatory injury was also specifically studied by depleting these cells with intravenous vinblastine before lung contusion. Arterial oxygenation was severely reduced at 8 min to 24 h postcontusion, but became almost normal by 48 h. Levels of erythrocytes, leukocytes, and albumin in BAL were increased at

Subject(s)
Contusions/metabolism , Cytokines/metabolism , Lung Injury , Thoracic Injuries/metabolism , Wounds, Nonpenetrating , Albumins/metabolism , Animals , Blood Pressure , Bronchiolitis Obliterans/metabolism , Bronchoalveolar Lavage Fluid , Chemokine CCL2/metabolism , Chemokine CCL8 , Chemokine CXCL2 , Chemokines, CXC/metabolism , Fibrosis/metabolism , Hemorrhage/pathology , Hypoxia , Inflammation , Intercellular Signaling Peptides and Proteins/metabolism , Interleukin-1/metabolism , Interleukin-6/metabolism , Lung/pathology , Monocyte Chemoattractant Proteins/metabolism , Monokines/metabolism , Neutropenia/drug therapy , Neutrophils/drug effects , Neutrophils/metabolism , Oxygen/metabolism , Pneumonia/metabolism , Pressure , Rats , Time Factors , Vinblastine/pharmacology
2.
Am J Physiol Lung Cell Mol Physiol ; 289(1): L134-43, 2005 Jul.
Article in English | MEDLINE | ID: mdl-15778247

ABSTRACT

A model of aspiration lung injury was developed in WT C57BL/6 mice to exploit genetically modified animals on this background, i.e., MCP-1(-/-) mice. Mice were given intratracheal hydrochloric acid (ACID, pH 1.25), small nonacidified gastric particles (SNAP), or combined acid plus small gastric particles (CASP). As reported previously in rats, lung injury in WT mice was most severe for "two-hit" aspiration from CASP (40 mg/ml particulates) based on the levels of albumin, leukocytes, TNF-alpha, IL-1beta, IL-6, MCP-1, KC, and MIP-2 in bronchoalveolar lavage (BAL) at 5, 24, and 48 h. MCP-1(-/-) mice given 40 mg/ml CASP had significantly decreased survival compared with WT mice (32% vs. 80% survival at 24 h and 0% vs. 72% survival at 48 h). MCP-1(-/-) mice also had decreased survival compared with WT mice for CASP aspirates containing reduced particulate doses of 10-20 mg/ml. MCP-1(-/-) mice given 5 mg/ml CASP had survival similar to WT mice given 40 mg/ml CASP. MCP-1(-/-) mice also had differing responses from WT mice for several inflammatory mediators in BAL (KC or IL-6 depending on the particle dose of CASP and time of injury). Histopathology of WT mice with CASP (40 mg particles/ml) showed microscopic areas of compartmentalization with prominent granuloma formation by 24 h, whereas lung tissue from MCP-1(-/-) mice had severe diffuse pneumonia without granulomas. These results indicate that MCP-1 is important for survival in murine aspiration pneumonitis and appears to act partly to protect uninjured lung regions by promoting isolation and compartmentalization of tissue with active inflammation.


Subject(s)
Chemokine CCL2/metabolism , Granuloma/metabolism , Lung/metabolism , Pneumonia, Aspiration/metabolism , Animals , Chemokine CCL2/genetics , Cytokines/biosynthesis , Granuloma/pathology , Hydrochloric Acid/toxicity , Lung/pathology , Mice , Mice, Knockout , Pneumonia, Aspiration/genetics , Pneumonia, Aspiration/pathology
3.
Clin Diagn Lab Immunol ; 11(4): 742-51, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15242950

ABSTRACT

The development of a nosocomial pneumonia is facilitated by alterations in host innate pulmonary antibacterial defenses following surgical trauma, which can result in decreased pulmonary bacterial clearance and increased morbidity and mortality. In a murine model of postoperative nosocomial infection, surgical stress (laparotomy) decreased Escherichia coli clearance from the lungs of animals that underwent surgery. Consistent with previous studies, (i) pulmonary levels of tumor necrosis factor alpha at 6 h and of interleukin-1beta (IL-1beta), IL-6, and gamma interferon (IFN-gamma) at 24 h post-bacterial infection (PBI) were decreased in animals that underwent laparotomy 24 h prior to E. coli infection (LAP/E. coli) compared to animals that received E. coli only; (ii) KC and macrophage inhibitory protein 2 were elevated at 6 h PBI in LAP/E. coli animals compared to E. coli-only animals; however, at 24 h PBI, levels were higher in the E. coli-only group; (iii) at 24 h PBI, monocyte chemoattractant protein 1 was lower in the LAP/E. coli group compared to the E. coli-only group; (iv) IL-10 levels were unaffected at all time points evaluated; and (v) the total number of neutrophils present in the lungs of LAP/E. coli animals at 6 h PBI was decreased in comparison to that in E. coli-only animals, resulting in decreased bacterial clearance and increased mortality in LAP/E. coli animals by 24 h PBI. Similar changes in cytokine profiles, pulmonary bacterial clearance, and mortality were consistent with reported findings in patients following surgical trauma. This model, therefore, provides a clinically relevant system in which the molecular and cellular mechanisms that lead to the development of nosocomial pneumonia can be further explored.


Subject(s)
Cross Infection/etiology , Cytokines/immunology , Pneumonia/etiology , Pneumonia/immunology , Postoperative Complications/immunology , Animals , Cross Infection/immunology , Disease Models, Animal , Escherichia coli/immunology , Escherichia coli Infections/immunology , Laparotomy/adverse effects , Lung/immunology , Lung/microbiology , Mice , Postoperative Complications/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...